Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
GLP-1 Receptor Agonists: Clinical Considerations and Risk Management for Patients Undergoing Ophthalmic Surgery
Caroline R Baumal1, Stephanie Choi1, Konstantin Balonov2
1New England Eye Center.
Abstract:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used to treat type 2 diabetes and obesity due to their benefits in glycemic control, weight loss, and cardiovascular risk reduction. However, their pharmacologic effect of delayed gastric emptying raises perioperative concerns. Even though ophthalmic procedures are often performed under local or topical anesthesia, there still remains the concern that GLP-1 RA-induced gastroparesis can increase the risk of aspiration. Additionally, adjunctive sedation, conversion to deeper sedation, or general anesthesia is sometimes necessary for ophthalmic surgery. This review outlines the perioperative implications of GLP-1 RA use in ophthalmic surgery, emphasizing the importance of preoperative screening, interdisciplinary coordination, and familiarity with the evolving anesthesia guidelines.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Oral Hypoglycemic Agents: Glinides
Ophthalmic Drug Delivery Systems
Glaucoma: Overview

